Improving the lives of children with glaucoma
![Lachlan Wheelhouse Knight JAB00361-Edit [FB share]](https://www.flindersfoundation.org.au/app/uploads/2021/07/Lachlan-Wheelhouse-Knight-JAB00361-Edit-FB-share.jpg)
Thanks to generous supporters of eye health at Flinders, researchers are hoping to improve the lives of children with glaucoma by identifying genes which lead to more severe outcomes, while also focusing on methods to improve quality of life for patients, and their families.
Lachlan Knight has received a Flinders Foundation top-up PhD scholarship to study 300 cases of childhood glaucoma in Australia and New Zealand.
“Childhood glaucoma is largely considered to be a genetic condition, yet we’ve found a ‘genetic answer’ for only around 40 per cent of patients,” Lachlan explains.
“This project is really looking at how many children are affected by the condition, what genes cause it, and if some genes cause more severe disease or have a greater impact on vision.
“If we can pinpoint this, then we hope to be able to identify those at risk of worse outcomes so they can get closer follow up and more intensive treatment to stop the progression of glaucoma.”
Lachlan’s work is also the first project in Australia, and one of just a few worldwide, to investigate the quality of life of kids with glaucoma and their families. Glaucoma is a rare condition caused by pressure on the optic nerve.
“Childhood glaucoma is a chronic condition needing life-long follow up,” Lachlan says.
“Some patients have vision loss and can have learning difficulties and social problems which stem from that, there can also be feelings of isolation and being misunderstood because there is a lack of awareness of the disease.
“For parents, they talk about stress, strong emotions and strain on the family, because many worry constantly for their child and what the future looks like for them.
“Some of these stories are quite heartbreaking, so this work is really looking at how families cope, what help they need, and how we can get them the necessary support.”
You can support eye health research at Flinders by making a donation Donate Now
More News
Stroke Rehab goes Virtual
Researchers from Flinders University and UniSA are set to develop a new rehabilitation technique for stroke survivors using state-of-the-art Virtual Reality (VR) technology.
Stroke Rehab goes Virtual
Researchers from Flinders University and UniSA are set to develop a new rehabilitation technique for stroke survivors using state-of-the-art Virtual Reality (VR) technology.
New Hope for Pancreatic Cancer
Dr Jean Winter and her Flinders University research team will soon begin trials of a world-first blood biomarker test for patients with pancreatic cancer.
New Hope for Pancreatic Cancer
Dr Jean Winter and her Flinders University research team will soon begin trials of a world-first blood biomarker test for patients with pancreatic cancer.
Help for families in gambling battle
The Southern Adelaide Local Health Network’s (SALHN) Statewide Gambling Therapy Service provides psychological therapies to individuals with gambling addictions.
Help for families in gambling battle
The Southern Adelaide Local Health Network’s (SALHN) Statewide Gambling Therapy Service provides psychological therapies to individuals with gambling addictions.
Rapid access to surgical procedures
Podiatrists at Noarlunga Hospital will trial a new model of care for anxious patients, to help them get rapid access to some minor surgical procedures.
Rapid access to surgical procedures
Podiatrists at Noarlunga Hospital will trial a new model of care for anxious patients, to help them get rapid access to some minor surgical procedures.
$1 Million in grants awarded
$1 million in grants awarded to 23 health and medical research projects across Southern Adelaide
$1 Million in grants awarded
$1 million in grants awarded to 23 health and medical research projects across Southern Adelaide
31 New Health and Medical Research Projects
Health and medical researchers across the Flinders Medical Precinct will share in $750,000 funding, to support exciting research projects across a variety of illnesses, diseases, and social issues.
31 New Health and Medical Research Projects
Health and medical researchers across the Flinders Medical Precinct will share in $750,000 funding, to support exciting research projects across a variety of illnesses, diseases, and social issues.
Grateful Tony Gives Back
Struggling to get a breath in and feeling like he was “choking to death”, Tony de Maaijer knew he was in a bad way.
Grateful Tony Gives Back
Struggling to get a breath in and feeling like he was “choking to death”, Tony de Maaijer knew he was in a bad way.
New Funding for Cancer Research
World Cancer Day (February 4) marked the announcement of funding for four new cancer research projects thanks to the generosity of guests and supporters of Flinders Foundation’s Pink Yellow Blue Enchanted Garden event.
New Funding for Cancer Research
World Cancer Day (February 4) marked the announcement of funding for four new cancer research projects thanks to the generosity of guests and supporters of Flinders Foundation’s Pink Yellow Blue Enchanted Garden event.
Tour de Cure’s New Mission to Tackle Head and Neck Cancers
Pedal power is helping to re-shape the monitoring of head and neck cancers in a bid to improve care for patients, particularly those in rural and regional areas.
Tour de Cure’s New Mission to Tackle Head and Neck Cancers
Pedal power is helping to re-shape the monitoring of head and neck cancers in a bid to improve care for patients, particularly those in rural and regional areas.
Ralph’s Legacy The Ralph Ernst Fellowship: Changing the Face of Survival in Prostate and Bladder Cancers
A generous man’s chance encounter with Flinders Medical Centre 35 years ago is now helping to change the future for men with prostate and bladder cancers.
Ralph’s Legacy The Ralph Ernst Fellowship: Changing the Face of Survival in Prostate and Bladder Cancers
A generous man’s chance encounter with Flinders Medical Centre 35 years ago is now helping to change the future for men with prostate and bladder cancers.